Zoltan Czigler

Zoltan Czigler has a diverse and extensive work experience in the financial sector. Zoltan has served as the Chief Financial Officer for multiple companies, including AB2 Bio Ltd., NXI Therapeutics AG, and Anergis SA. Zoltan has also held the role of CFO and member of the Board at ChromaCon AG, where they were involved in developing and commercializing proprietary chromatographic process technology. In addition, Zoltan has worked as a Corporate Finance & IT Consultant at their own company, as well as a Consultant at Nuclear Finance AG. Zoltan has experience as a Director of Finance at Kuros Biosurgery AG and as an Investment Manager at VI Partners AG. Zoltan's expertise also extends to venture management, having worked as a Venture Manager at Speed Ventures GmbH.

Zoltan Czigler has an MBA degree from INSEAD, which they obtained from 1999 to 2000. Prior to that, they completed their MSc in Engineering Mathematics from Budapest University of Technology and Economics from 1985 to 1991. Zoltan also attended ELTE Radnóti Miklós Gyakorló Gimnázium from 1980 to 1984, where they completed their secondary school education.